A randomized controlled trial comparing the first-line eradication rate using vonoprazan or PPI for Helicobacter pylori infectious gastritis.

Trial Profile

A randomized controlled trial comparing the first-line eradication rate using vonoprazan or PPI for Helicobacter pylori infectious gastritis.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Vonoprazan (Primary) ; Amoxicillin; Clarithromycin; Lansoprazole; Rabeprazole
  • Indications Gastritis; Helicobacter pylori infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 31 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top